| Name | Title | Contact Details |
|---|---|---|
Alexander Laham |
Chief Compliance Officer | Profile |
Visus Therapeutics is a clinical-stage company in pursuit of developing the world`s first presbyopia-correcting eye drop with the potential to last at least eight hours. With offices in Seattle, Washington, and Orange County, California, our lead clinical candidate is VTI-001 (BRIMOCHOLâ„¢), a once-daily eye drop designed to correct the loss of near vision associated with presbyopia. In parallel, Visus Therapeutics is focused on advancing its pipeline of early-stage ophthalmic product candidates.
Apnimed is a clinical-stage company focused on advancing oral medicines to treat Obstructive Sleep Apnea (OSA) and related disorders.
Circassia Pharmaceuticals is a specialty biopharmaceutical company developing a range of immunotherapies.
Nutraceutics Corp is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Custom coater, converter and packager for the medical, electronics, automotive and general industrial markets.